Related Experiment Video
Updated: Jul 2, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Helicases as antiviral drug targets
J D Huang1, B J Zheng, H Z Sun
1Department of Biochemistry, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong. jdhuang@hkucc.hku.hk
Abstract:
1. We have demonstrated for the first time that the helicase of a ribonucleic acid virus, the SARS coronavirus (SARS-CoV), is a valid target for drug development. 2. Using high throughput screen and chemical synthesis, several lead compounds targeting the SARS-CoV helicase have been identified. We have shown that these compounds can inhibit SARS-CoV helicase activity and viral growth in cell culture systems. These compounds can potentially be used to target other viruses.
Related Concept Videos
DNA Helicases
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release

